These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31760657)

  • 1. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.
    Murakami T; Sunada Y
    Adv Exp Med Biol; 2019; 1190():371-378. PubMed ID: 31760657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
    Sousa MM; Saraiva MJ
    Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin is not expressed by dorsal root ganglia cells.
    Sousa MM; Saraiva MJ
    Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with familial amyloid polyneuropathy transthyretin E61K.
    Murakami T; Watanabe H; Yamamoto A; Sunada Y
    J Neurol Sci; 2022 Sep; 440():120329. PubMed ID: 35777313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: a quantitative light and electron microscopic study of the peripheral nervous system.
    Toyooka K; Fujimura H; Ueno S; Yoshikawa H; Kaido M; Nishimura T; Yorifuji S; Yanagihara T
    Acta Neuropathol; 1995; 90(5):516-25. PubMed ID: 8560986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis.
    Murakami T; Ito Y; Sango K; Watabe K; Sunada Y
    Neurochem Int; 2023 Mar; 164():105507. PubMed ID: 36796540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transthyretin familial amyloid polyneuropathy].
    Kopishinskaya SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial amyloid polyneuropathy: mechanisms leading to nerve degeneration.
    Said G
    Amyloid; 2003 Aug; 10 Suppl 1():7-12. PubMed ID: 14640035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
    Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
    Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Neuropathy: From Pathophysiology to Treatment in Light-Chain Amyloidosis and Hereditary Transthyretin Amyloidosis.
    Chompoopong P; Mauermann ML; Siddiqi H; Peltier A
    Ann Neurol; 2024 Sep; 96(3):423-440. PubMed ID: 38923548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
    Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
    Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
    J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
    Hou X; Aguilar MI; Small DH
    FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
    Adams D; Koike H; Slama M; Coelho T
    Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.